Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Soloway

Showing results (11-20 of 252) with videos related to

Pageof 26
Sort By:
European Urology|December 3, 2013
Re: overdiagnosis and overtreatment in cancer: an opportunity for improvementMark S Soloway
Urology|April 3, 2002
Progression and survival in patients with T1G3 bladder tumorsMark S Soloway
BJU International|September 26, 2018
Postoperative intravesical chemotherapy has an important role in reducing subsequent bladder tumours - why is it not routine?Mark S Soloway
European Urology|August 11, 2007
Thromboembolism prophylaxis and total prostatectomy: is pharmacologic therapy required?Mark S Soloway
The Canadian Journal of Urology|February 19, 2009
Legends of urologyMark S Soloway
Cancer|April 1, 2018
The Management of Superficial Bladder CancerMark S Soloway
Bladder Cancer (Amsterdam, Netherlands)|May 8, 2018
Challenging Cases in Urothelial CancerMark S Soloway
Nature Reviews. Urology|February 17, 2016
Bladder cancer: Active surveillance for low-grade Ta bladder tumoursMark S Soloway
Current Urology Reports|July 27, 2016
Ct2 Bladder CancerMark S Soloway
Urology|November 14, 2002
Timing of androgen deprivation for prostate cancer: benefits versus side effects--a patient-physician dialogueMark S Soloway
Pageof 26

Showing results (11-20 of 252) with videos related to

Sort By:
Pageof 26
European Urology|December 3, 2013
Re: overdiagnosis and overtreatment in cancer: an opportunity for improvementMark S Soloway
Urology|April 3, 2002
Progression and survival in patients with T1G3 bladder tumorsMark S Soloway
BJU International|September 26, 2018
Postoperative intravesical chemotherapy has an important role in reducing subsequent bladder tumours - why is it not routine?Mark S Soloway
European Urology|August 11, 2007
Thromboembolism prophylaxis and total prostatectomy: is pharmacologic therapy required?Mark S Soloway
The Canadian Journal of Urology|February 19, 2009
Legends of urologyMark S Soloway
Cancer|April 1, 2018
The Management of Superficial Bladder CancerMark S Soloway
Bladder Cancer (Amsterdam, Netherlands)|May 8, 2018
Challenging Cases in Urothelial CancerMark S Soloway
Nature Reviews. Urology|February 17, 2016
Bladder cancer: Active surveillance for low-grade Ta bladder tumoursMark S Soloway
Current Urology Reports|July 27, 2016
Ct2 Bladder CancerMark S Soloway
Urology|November 14, 2002
Timing of androgen deprivation for prostate cancer: benefits versus side effects--a patient-physician dialogueMark S Soloway
Pageof 26